FAAH假基因微缺失致高内源性大麻素与痛觉不敏感
一例66岁女性在骨科手术后无需镇痛,终生无痛性损伤且愈合快,基因分析发现其共遗传FAAH-OUT微缺失与FAAH功能性SNP,循环内源性大麻素显著升高,提示FAAH功能丧失与增强内源性大麻素信号导致痛觉不敏感。
要点
- FAAH-OUT微缺失与FAAH低功能SNP共遗传可致痛觉不敏感。
- 该患者循环anandamide及相关脂肪酸酰胺显著升高。
- 靶向FAAH-OUT可能为术后及慢性疼痛提供新镇痛策略。
核心结论
- FAAH-OUT微缺失与FAAH低功能SNP共遗传导致FAAH功能丧失和痛觉不敏感。
研究设计与样本
- 对一例66岁女性痛觉不敏感患者进行遗传与生化分析,并与携带低功能SNP的正常对照比较。
主要发现
- 患者术后无需镇痛,终生无痛性损伤且愈合快。
- 患者共遗传FAAH-OUT微缺失和FAAH功能性SNP。
- 患者循环anandamide、palmitoylethanolamide和oleoylethanolamine显著高于正常对照。
临床怎么用
- FAAH-OUT可作为开发FAAH相关镇痛药的新靶点。
- 该发现可能改善术后疼痛、慢性疼痛和焦虑障碍的治疗。
局限性
- 证据来自单例患者与对照比较,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The study of rare families with inherited pain insensitivity can identify new human-validated analgesic drug targets. Here, a 66-yr-old female presented with nil requirement for postoperative analgesia after a normally painful orthopaedic hand surgery (trapeziectomy). Further investigations revealed a lifelong history of painless injuries, such as frequent cuts and burns, which were observed to heal quickly. We report the causative mutations for this new pain insensitivity disorder: the co-inheritance of (i) a microdeletion in dorsal root ganglia and brain-expressed pseudogene, FAAH-OUT, which we cloned from the fatty-acid amide hydrolase (FAAH) chromosomal region; and (ii) a common functional single-nucleotide polymorphism in FAAH conferring reduced expression and activity. Circulating concentrations of anandamide and related fatty-acid amides (palmitoylethanolamide and oleoylethanolamine) that are all normally degraded by FAAH were significantly elevated in peripheral blood compared with normal control carriers of the hypomorphic single-nucleotide polymorphism. The genetic findings and elevated circulating fatty-acid amides are consistent with a phenotype resulting from enhanced endocannabinoid signalling and a loss of function of FAAH. Our results highlight previously unknown complexity at the FAAH genomic locus involving the expression of FAAH-OUT, a novel pseudogene and long non-coding RNA. These data suggest new routes to develop FAAH-based analgesia by targeting of FAAH-OUT, which could significantly improve the treatment of postoperative pain and potentially chronic pain and anxiety disorders.
引用
- Habib AM, Okorokov AL, Hill MN, et al. Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity. Br J Anaesth. 2019. PMID: 30929760. doi:10.1016/j.bja.2019.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。